Jiangsu HengRui Medicine Co., Ltd. clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 2 with minor changes only.

1. Notable

   Hetrombopag Olamine Tablets Vs Placebo · Chemotherapy-Induced…Hetrombopag Olamine Tablets Vs Placebo · Chemotherapy-Induced Thrombocytopenia (ExCIT)

   Primary endpoint(s) modified

   Also in this update: Trial sites expanded: 7 → 51 locations; Interventions modified

   Jiangsu HengRui Medicine Co., Ltd.·Phase 3· NCT07286032· Registry history of NCT07286032 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

2. Notable

   FH-006 for Injection · Malignant Solid Tumors

   Primary endpoint(s) modified

   Also in this update: Interventions modified

   Jiangsu HengRui Medicine Co., Ltd.·Phase 1/2· NCT07136142· Registry history of NCT07136142 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

3. Notable

   HRS-8427 · Complicated Urinary Tract Infection, Including Acute…HRS-8427 · Complicated Urinary Tract Infection, Including Acute Pyelonephritis

   Primary and study completion pushed from Nov 2025 to Nov 2026

   Also in this update: Enrollment closed, study ongoing; and 2 more changes in the last 30 days

   Jiangsu HengRui Medicine Co., Ltd.·Phase 3· NCT06569056· Registry history of NCT06569056 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

4. Notable

   Bupivacaine Liposome Injection in Local Analgesia of Pediatric…Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

   Primary completion pushed from Sep 28, 2026 to May 2027

   Also in this update: Study completion pushed from Oct 12, 2026 to May 2027

   Jiangsu HengRui Medicine Co., Ltd.·Phase 4· NCT06344091· Registry history of NCT06344091 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

5. Notable

   HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus…HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults

   Recruitment opened

   Jiangsu HengRui Medicine Co., Ltd.·Phase 3· NCT07746726· Registry history of NCT07746726 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

6. Notable

   HRS-8427 · Bacterial Pneumonia

   Primary completion date changed from estimate of Feb 2026 to Sep 22, 2026

   Also in this update: Enrollment closed, study ongoing; Final enrollment: 120 participants (planned 100)

   Jiangsu HengRui Medicine Co., Ltd.·Phase 2· NCT06841731· Registry history of NCT06841731 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.